Cardiovascular disease in peritoneal dialysis: A review

Vanholder, 2005, Chronic kidney disease as cause of cardiovascular morbidity and mortality, Nephrol Dial Transplant, 20, 1048, 10.1093/ndt/gfh813 US Department of Public Health and Human Services, Public Health Service, National Institutes of Health, Bethesda, 2009. United States Renal Data System. Bleyer, 2006, Characteristics of sudden death in hemodialysis patients, Kidney Int, 69, 2268, 10.1038/sj.ki.5000446 Stenvinkel, 2008, Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?, Clin J Am Soc Nephrol, 3, 505, 10.2215/CJN.03670807 Chiu, 2010, Can we reduce the cardiovascular risk in peritoneal dialysis patients?, Indian J Nephrol, 20, 59, 10.4103/0971-4065.65296 Phakdeekitcharoen, 2004, Effects of an ACE inhibitor or angiotensin receptor blocker on potassium in CAPD patients, Am J Kidney Dis, 44, 738, 10.1016/S0272-6386(04)00954-0 Pernod, 2006, Phenotypic and genotypic risk factors for cardiovascular events in an incident dialysis cohort, Kidney Int, 69, 1424, 10.1038/sj.ki.5000312 Liu, 2004, Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition, JAMA, 291, 451, 10.1001/jama.291.4.451 Wanner, 2005, Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis, N Engl J Med, 353, 238, 10.1056/NEJMoa043545 Bredie, 2001, Effects of peritoneal dialysis with an overnight icodextrin dwell on parameters of glucose and lipid metabolism, Perit Dial Int, 21, 275, 10.1177/089686080102100308 Mehrotra, 2008, Hypovitaminosis D and chronic kidney disease, Clin J Am Soc Nephrol, 3, 1144, 10.2215/CJN.05781207 Wolf, 2007, Vitamin D levels and early mortality among incident hemodialysis patients, Kidney Int, 72, 1004, 10.1038/sj.ki.5002451 Mehrotra, 2009, Chronic kidney disease, hypovitaminosis D, and mortality in the United States, Kidney Int, 76, 977, 10.1038/ki.2009.288 Kalpakian, 2007, Vascular calcification and disordered mineral metabolism in dialysis patients, Semin Dial, 20, 139, 10.1111/j.1525-139X.2007.00261.x Mehrotra, 2007, Serum phosphorus and mortality in chronic peritoneal dialysis (CPD) patients, Perit Dial Int, 27, S12 Noordzij, 2006, Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients, Nephrol Dial Transplant, 21, 2513, 10.1093/ndt/gfl257 Sedlacek, 2000, Relationship between phosphorus and creatinine clearance in peritoneal dialysis: clinical implications, Am J Kidney Dis, 36, 1020, 10.1053/ajkd.2000.19105 Wang, 2004, Hyperphosphatemia in Chinese peritoneal dialysis patients with and without residual kidney function: what are the implications?, Am J Kidney Dis, 43, 712, 10.1053/j.ajkd.2003.12.032 Medcalf, 2001, Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis, Kidney Int, 59, 1128, 10.1046/j.1523-1755.2001.0590031128.x Kolesnyk, 2009, A positive effect of AII inhibitors on peritoneal membrane function in long-term PD patients, Nephrol Dial Transplant, 24, 272, 10.1093/ndt/gfn421 Fine, 1997, Commonly prescribed salt intake in continuous ambulatory peritoneal dialysis patients is too restrictive: results of a double-blind crossover study, J Am Soc Nephrol, 8, 1311, 10.1681/ASN.V881311 Losito, 2003, Association of interleukin-6-174G/C promoter polymorphism with hypertension and left ventricular hypertrophy in dialysis patients, Kidney Int, 64, 616, 10.1046/j.1523-1755.2003.00119.x Herzig, 2001, Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients?, J Am Soc Nephrol, 12, 814, 10.1681/ASN.V124814 Ducloux, 2006, Impact of malnutrition inflammation on the association between homocysteine and mortality, Kidney Int, 69, 331, 10.1038/sj.ki.5000096 Wang, 2005, Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients, Am J Kidney Dis, 45, 715, 10.1053/j.ajkd.2004.12.012 Mak, 1996, Insulin resistance in uremia: effect of dialysis modality, Pediatr Res, 40, 304, 10.1203/00006450-199608000-00019 Kobayashi, 2000, Impact of dialysis therapy on insulin resistance in end-stage renal disease: comparison of haemodialysis and continuous ambulatory peritoneal dialysis, Nephrol Dial Transplant, 15, 65, 10.1093/ndt/15.1.65 Amici, 2001, Hyperinsulinism reduction associated with icodextrin treatment in continuous ambulatory peritoneal dialysis patients, Adv Perit Dial, 17, 80 Kalantar-Zadeh, 2007, Hepatitis C virus and death risk in hemodialysis patients, J Am Soc Nephrol, 18, 1584, 10.1681/ASN.2006070736 Haubitz, 2001, C-reactive protein and chronic Chlamydia pneumoniae infection–long-term predictors for cardiovascular disease and survival in patients on peritoneal dialysis, Nephrol Dial Transplant, 16, 809, 10.1093/ndt/16.4.809 Troidle, 1998, Differing outcomes of gram-positive and gram-negative peritonitis, Am J Kidney Dis, 32, 623, 10.1016/S0272-6386(98)70026-5 Fried, 1996, Peritonitis influences mortality in peritoneal dialysis patients, J Am Soc Nephrol, 7, 2176, 10.1681/ASN.V7102176 Lam, 2007, Hyperleptinaemia and chronic inflammation after peritonitis predicts poor nutritional status and mortality in patients on peritoneal dialysis, Nephrol Dial Transplant, 22, 1445, 10.1093/ndt/gfl788 Dong, 2002, DNA methylation and atherosclerosis, J Nutr, 132, 2406S, 10.1093/jn/132.8.2406S Akcay, 2006, Relationship of eNOS and ras gene polymorphisms to initial peritoneal transport status in peritoneal dialysis patients, Nephron Clin Pract, 104, c41, 10.1159/000093669 Gillerot, 2005, Genetic and clinical factors influence the baseline permeability of the peritoneal membrane, Kidney Int, 67, 2477, 10.1111/j.1523-1755.2005.00357.x